CAPREIT Announces Departure of Chief Investment Officer

CAPREIT Announces Departure of Chief Investment Officer GlobeNewswire January 13, 2026 This news release constitutes a “designated news release” for the purposes of CAPREIT's prospectus supplement dated May 15, 2025, to its short form base shelf prospectus dated May 15, 2025. Not for distribution to U.S. newswire services or for dissemination in the United States. […]

Fancamp Awarded ECOLOGO Certification for Responsible Mineral Exploration from UL Solutions

Fancamp Awarded ECOLOGO Certification for Responsible Mineral Exploration from UL Solutions GlobeNewswire January 13, 2026 VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation“) (TSX Venture Exchange: FNC) is pleased to announce that it has achieved ECOLOGO(R) Certification for ULC TS-2723 Responsible Development for Mineral Exploration Industry (the

Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors

(NASDAQ:CVRX), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Wolf Popper LLP is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx”) common stock (NASDAQ: CVRX). CVRx is a medical device company. CVRx's principal product is Barostim, which acts like a pacemaker. On April 30, 2024, CVRx announced weak first quarter results, which

Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors

Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Wolf Popper LLP is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx”) common stock (NASDAQ: CVRX). CVRx is a medical device company. CVRx's principal product is Barostim, which acts

/C O R R E C T I O N — Armata Pharmaceuticals, Inc./

In the news release, Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus, issued Jan. 13, 2026 by Armata Pharmaceuticals, Inc. over PR Newswire, we are advised by the company that the original version contained incorrect information introduced by PR Newswire during

Spread.NET v19 Launched by MESCIUS USA, Inc.

MESCIUS USA, Inc., a global provider of award-winning enterprise software development tools, is pleased to announce the Spread.NET v19 release. This latest update delivers significant new enhancements across both Spread for Windows Forms and WPF. The release expands analytical capabilities, improves usability, and offers deeper customization options–making it easier than ever for developers to build

Oula Named Modern Healthcare 2025 Best in Business Honoree

Oula’s collaborative care model demonstrates how integrating midwives and OBGYNs creates better outcomes for patients and providers. Oula, a collaborative maternity care practice that provides comprehensive gynecology and pregnancy care, has been named a Modern Healthcare 2025 Best in Business Award honoree in the “Patient Experience & Engagement” category. The program recognizes organizations that drive

Carolinas Contractors See Strong Opportunities in Key Markets Despite Broader Uncertainty

Results from AGC of America’s newly released 2026 Construction Outlook show that contractors across the Carolinas are entering the New Year with cautious optimism, especially in healthcare, power, water/sewer, and data center markets. While national expectations have “dampened” overall, North Carolina and South Carolina firms continue to report notable areas of momentum, along with steady

Green Shift Commodities Announces Options Grant

(TSX-V:GCOM),(OTC US:GRCMF),(Other OTC:GRCMF), TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Green Shift Commodities Ltd. (TSXV: GCOM and OTCQB: GRCMF), (“Green Shift“, “GCOM” or the “Company“) is announcing that it has granted a total of 3,000,000 stock options (“Options“) to various directors, officers, and consultants of the Company. Each option is exercisable to acquire one Common

Scroll to Top